A report for the fifth International Workshop on Rotavirus and Norovirus in China.

IF 3.5 4区医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Human Vaccines & Immunotherapeutics Pub Date : 2025-12-01 Epub Date: 2025-06-09 DOI:10.1080/21645515.2025.2512647

Si-Jie Wang, Roger Glass, Baoming Jiang, Carl Kirkwood, Umesh Parashar, Zhao-Jun Duan, Xuan-Yi Wang

{"title":"A report for the fifth International Workshop on Rotavirus and Norovirus in China.","authors":"Si-Jie Wang, Roger Glass, Baoming Jiang, Carl Kirkwood, Umesh Parashar, Zhao-Jun Duan, Xuan-Yi Wang","doi":"10.1080/21645515.2025.2512647","DOIUrl":null,"url":null,"abstract":"<p><p>The fifth International Workshop on Rotavirus and Norovirus in China was convened in Shanghai May 8-9, 2024. The workshop was organized by Fudan University and China Center for Disease Control and Prevention (China CDC), with strong support from Bill & Melinda Gates Foundation and the Centers for Disease Control and Prevention in the United States (US CDC). Over 230 participants from 10 countries, including experts and representatives from government and non-government organizations, academia and vaccine manufacturers, attended the meeting. Progress on reduced rotavirus disease burden, the impact of currently licensed oral vaccines, new vaccines and technologies under development to control and prevent acute gastroenteritis caused by rotavirus and norovirus, mucosal immunity and its measurement, as well as the association between the effectiveness of rotavirus vaccine and intestinal microbiome were discussed extensively. This report summarized the latest information shared at the convening.</p>","PeriodicalId":49067,"journal":{"name":"Human Vaccines & Immunotherapeutics","volume":"21 1","pages":"2512647"},"PeriodicalIF":3.5000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12150633/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Vaccines & Immunotherapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21645515.2025.2512647","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

The fifth International Workshop on Rotavirus and Norovirus in China was convened in Shanghai May 8-9, 2024. The workshop was organized by Fudan University and China Center for Disease Control and Prevention (China CDC), with strong support from Bill & Melinda Gates Foundation and the Centers for Disease Control and Prevention in the United States (US CDC). Over 230 participants from 10 countries, including experts and representatives from government and non-government organizations, academia and vaccine manufacturers, attended the meeting. Progress on reduced rotavirus disease burden, the impact of currently licensed oral vaccines, new vaccines and technologies under development to control and prevent acute gastroenteritis caused by rotavirus and norovirus, mucosal immunity and its measurement, as well as the association between the effectiveness of rotavirus vaccine and intestinal microbiome were discussed extensively. This report summarized the latest information shared at the convening.

查看原文本刊更多论文

中国第五届轮状病毒和诺如病毒国际研讨会报告。

第五届轮状病毒与诺如病毒国际研讨会于2024年5月8日至9日在上海召开。本次研讨会由复旦大学和中国疾病预防控制中心主办，得到了比尔及梅琳达·盖茨基金会和美国疾病预防控制中心的大力支持。来自10个国家的230多名与会者出席了会议，其中包括来自政府和非政府组织、学术界和疫苗制造商的专家和代表。讨论了减轻轮状病毒疾病负担的进展、目前已批准的口服疫苗的影响、控制和预防由轮状病毒和诺如病毒引起的急性胃肠炎的新疫苗和正在开发的新技术、粘膜免疫及其测量、以及轮状病毒疫苗的有效性与肠道微生物群之间的关系。本报告总结了在会议上分享的最新信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY

CiteScore

7.90

自引率

8.30%

发文量

489

审稿时长

3-6 weeks

期刊介绍： (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.